Vaccine safety and Efficacy

The vaccines are always recommended for use after it gets licensed by the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC). Every authorized and approved vaccine goes through safety testing, effectiveness, and clinical trials. Vaccine safety is monitored after it is recommended for infants, children, and adults. Efficacy in a vaccine is measured by how it performs in ideal conditions and controlled clinical trials. Effectiveness can differ from efficacy as we can’t predict exactly how effective the vaccine is in the real world when compared to clinical trials results. For complete protection, it takes time but all the doses of the vaccine should be taken.

Related associations and societies: Clinical Immunology Society, Hepatitis B Foundation (HBF)Pediatric Infectious Diseases Society(PIDS)Indian Vaccine Manufacturers Association (IVMA),Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI),  National Medical Association (NMA), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)Immune Deficiency Foundation (IDF), Federation of Clinical Immunology Societies (FOCIS)

    Related Conference of Vaccine safety and Efficacy

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    September 09-10, 2024

    7th International Conference on Vaccines and Immunology

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Vaccine safety and Efficacy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in